Search Results
Site Search
MML Regional Manager Kate Lynch Bix Retires after 29 Years of Dedicated Service - Insights
Kate Lynch Bix, Mayo Medical Laboratories (MML) Regional Manager, says goodbye after 29 years of dedicated service. When Kate joined MML in 1988, she joined the team of only eight sales staff responsible for covering the entire United...
Mayo Clinic Laboratory and pathology research roundup: December 14 - Insights
This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.
Mayo Clinic Laboratory and pathology research roundup: January 11 - Insights
This week’s research roundup features: The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Muscle and nerve biopsy consultation - Insights
Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.
March 2022 - Cardiovascular Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.
September 2020 — Clinical Microbiology, Hematology, Hematopathology, & Infectious Disease - Insights
This "Pathways" program provides a Anatomic and Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology, Hematology, Hematopathology, and...
Pathways Case Studies: March 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Bone and Soft Tissue, Clinical...
Pathways Case Studies: September 2019 - Insights
Mayo Clinic laboratory experts share five case studies in this month’s “PathWays” post and are challenging you to test your laboratory genetics & genomics, bone & soft tissue, renal, infectious disease, and gastroenterology pathology...
Therapeutic drug monitoring - Insights
Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.
Week in Review: April 15 - Insights
Today's highlights include: Facing 'alarming' health care worker shortage, unusual cases of hepatitis in young children, and why women's risk of heart disease increased during the pandemic.
Respiratory viruses - Insights
Browse our full suite of serology and PCR testing for respiratory viruses like influenza, RSV, and more.
numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance...
Testing Archives - Page 21 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 9 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 10 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 20 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 11 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 12 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 19 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 18 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 17 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Appropriate Use of Gastrointestinal Pathogen Panel by PCR [Utilization Spotlight] - Insights
Infectious diarrhea is a common and usually self-limited illness. While most patients with infectious causes of diarrhea will get better on their own, there are certain scenarios in which testing is indicated. The The FilmArray...
Testing Archives - Page 24 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 23 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Hot Topic Archives - Page 3 of 5 - Insights
Skip to Content MayoACCESS MayoLINK...
Hot Topic Archives - Page 5 of 5 - Insights
Skip to Content MayoACCESS MayoLINK...
Jeff Meeusen, Ph.D., Provides Clinical Update on Ceramides - Insights
Jeff Meeusen, Ph.D., Co-Director of Cardiovascular Laboratory Medicine in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, provides a clinical update on ceramides.
Whole exome sequencing - Insights
Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.
Against the odds: Alex Kraatz - Insights
As a two-time brain tumor survivor, Alex Kraatz has been through more harrowing medical experiences in his 34 years than most people face in a lifetime. But Alex’s fighting spirit, coupled with precision laboratory testing and cutting-edge...
Transformative diagnostics - Insights
With a sophisticated laboratory test catalog and thousands of Mayo Clinic experts, we’re here to help you answer the toughest clinical questions.
Mayo Clinic Laboratories’ commitment to pediatric care is supported by over 150 years of experience informing diagnoses and treatment plans.
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the...
Vector-borne diseases - Insights
Browse our full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases.
Offering more than 150 oncology-specific tests in nine subspecialty areas, Mayo Clinic Laboratories’ cancer tests are developed by an experienced team of board-certified geneticists, genetic counselors, and physicians.
An uncommon antibody, a life restored: Jori Pearson - Insights
Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves.
Preparation of Platelet-Poor Plasma for Special Coagulation Testing - Insights
In this months "Hot Topic," Christopher Desens, MLS(ASCP) discusses the preparation of platelet-poor plasma for coagulation testing.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Next-generation sequencing: Examining an often oversimplified & misunderstood technology--Part I
In the last decade, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays.
A downward spiral undone: Jon Bratsch - Insights
Lying in an ICU bed as sick as he could get, Jon Bratsch thought he was past the point of no return. But when a Mayo Clinic Laboratories’ test revealed the source of his dire symptoms, everything changed. Today, Jon’s back to the life and...
A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...
Frequently asked questions - Insights
Read answers to frequently asked questions about prenatal testing at Mayo Clinic Laboratories, including specimen requirements, maternal cell contamination testing, pricing, and more.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Finding the Balance: Legal Issues Arising from Precision Medicine - Insights
By taking into account an individual’s genes, lifestyle, and environment, precision medicine offers the prospect of finding individualized therapies that might ultimately cure diseases such as cancer and diabetes. Yet, as with other...
Unraveling a diagnostic mystery: Ed Garber - Insights
Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the...
Frozen and on Time: Rapid Margin Assessment Helps Prevent Repeat Surgeries - Insights
A breakthrough in pathology, achieved more than a century ago (allegedly on a frozen window ledge in Rochester, Minnesota) has evolved into an innovative aspect of care at Mayo Clinic. Mayo is one of the only medical centers in the United...
Medical Drones: High Hopes, Grounded in Science - Insights
While online retailers experiment with drones as a way to swiftly deliver consumer purchases, laboratory medicine physicians and scientists have a lifesaving goal: using drones to rapidly deliver laboratory specimens.
Modified two-tiered testing for Lyme disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).